Reuters logo
BRIEF-Elan says Royalty Pharma bid highly opportunistic
February 25, 2013 / 2:25 PM / 5 years ago

BRIEF-Elan says Royalty Pharma bid highly opportunistic

DUBLIN, Feb 25 (Reuters) - Elan Corporation PLC : * Acknowledges this morning’s announcement by royalty management, llc * Expect the tysabri transaction to close in the near future. * Says timing of royalty pharma offer highly opportunistic * Says any credible proposal will of course be considered

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below